The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia

Samyuktha Melachuri(University of Pittsburgh), Bruce Bostrom(Minnesota West Community & Technical College), Laura M. Gandrud(Stanford University)

Pediatric Blood & Cancer

January 10, 2014

10.1002/pbc.24928

Cited by 35

Related Papers

A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

|Blood|2002|496

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

|Blood|2003|361

Association of Hypoglycemia, Hyperglycemia, and Glucose Variability With Morbidity and Death in the Pediatric Intensive Care Unit

|PEDIATRICS|2006|359

Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia

|New England Journal of Medicine|1987|334

Juvenile xanthogranuloma: Forms of systemic disease and their clinical implications

|The Journal of Pediatrics|1996|294